InChI=1S/C37H46N14O14S/c1-16-29(66-37(44-16)49-31(61)17-6-3-2-4-7-17)19-10-23(51-50-19)33(63)43-14-24(52)45-18(8-5-9-41-36(39)40)32(62)42-15-25(53)46-21(12-27(56)57)34(64)48-22(13-28(58)59)35(65)47-20(30(38)60)11-26(54)55/h2-4,6-7,10,18,20-22H,5,8-9,11-15H2,1H3,(H2,38,60)(H,42,62)(H,43,63)(H,45,52)(H,46,53)(H,47,65)(H,48,64)(H,50,51)(H,54,55)(H,56,57)(H,58,59)(H4,39,40,41)(H,44,49,61)/t18-,20-,21-,22-/m1/s1 |
OPFJDXRVMFKJJO-ZHHKINOHSA-N |
C(CNC(=O)[C@H](NC(=O)CNC(C1=CC(=NN1)C=2SC(=NC2C)NC(C3=CC=CC=C3)=O)=O)CCCNC(N)=N)(N[C@@H](C(N[C@@H](C(N[C@@H](C(N)=O)CC(=O)O)=O)CC(=O)O)=O)CC(=O)O)=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
angiotensin receptor agonist
A hormone antagonist that acts at angiotensin receptors.
|
|
angiotensin receptor agonist
A hormone antagonist that acts at angiotensin receptors.
|
|
View more via ChEBI Ontology
Outgoing
|
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
(CHEBI:138409)
has role
angiotensin receptor agonist
(CHEBI:138416)
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
(CHEBI:138409)
is a
1,3-thiazoles
(CHEBI:38418)
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
(CHEBI:138409)
is a
benzamides
(CHEBI:22702)
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
(CHEBI:138409)
is a
biaryl
(CHEBI:64459)
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
(CHEBI:138409)
is a
oligopeptide
(CHEBI:25676)
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
(CHEBI:138409)
is a
pyrazoles
(CHEBI:26410)
|
|
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazol-5-yl]carbonyl}glycyl-D-arginylglycyl-D-α-aspartyl-D-α-aspartyl-D-α-asparagine
|
cmpd21
|
ChEBI
|
compound 21
|
ChEBI
|
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-GdRGdDdDdD-NH2
|
ChEBI
|
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-Gly-D-Arg-Gly-D-α-Asp-D-α-Asp-D-α-Asp-NH2
|
ChEBI
|
25999889
|
Reaxys Registry Number
|
Reaxys
|
22184324
|
PubMed citation
|
Europe PMC
|
22802221
|
PubMed citation
|
Europe PMC
|
23164706
|
PubMed citation
|
SUBMITTER
|
24041944
|
PubMed citation
|
Europe PMC
|
24329698
|
PubMed citation
|
Europe PMC
|
24361310
|
PubMed citation
|
Europe PMC
|
24508710
|
PubMed citation
|
Europe PMC
|
24687998
|
PubMed citation
|
Europe PMC
|
24752645
|
PubMed citation
|
Europe PMC
|
24914880
|
PubMed citation
|
Europe PMC
|
25186297
|
PubMed citation
|
Europe PMC
|
25304472
|
PubMed citation
|
Europe PMC
|
25398877
|
PubMed citation
|
SUBMITTER
|
25560767
|
PubMed citation
|
Europe PMC
|
25753301
|
PubMed citation
|
Europe PMC
|
25776077
|
PubMed citation
|
Europe PMC
|
26783414
|
PubMed citation
|
Europe PMC
|
27168137
|
PubMed citation
|
Europe PMC
|
28099262
|
PubMed citation
|
Europe PMC
|
28192099
|
PubMed citation
|
Europe PMC
|
28456626
|
PubMed citation
|
Europe PMC
|
28711702
|
PubMed citation
|
Europe PMC
|
|